4//SEC Filing
SHROTRIYA RAJESH C MD 4
Accession 0001104659-22-065264
CIK 0000895051other
Filed
May 25, 8:00 PM ET
Accepted
May 26, 4:11 PM ET
Size
8.3 KB
Accession
0001104659-22-065264
Insider Transaction Report
Form 4
SHROTRIYA RAJESH C MD
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-05-25+345,806→ 345,806 totalExercise: $0.47Exp: 2032-05-25→ Common Stock (345,806 underlying)
Footnotes (1)
- [F1]Stock option award will vest ratably quarterly to the end of the year.
Issuer
CASI Pharmaceuticals, Inc.
CIK 0000895051
Entity typeother
Related Parties
1- filerCIK 0001193918
Filing Metadata
- Form type
- 4
- Filed
- May 25, 8:00 PM ET
- Accepted
- May 26, 4:11 PM ET
- Size
- 8.3 KB